Literature DB >> 11461710

Differential analysis of behavior and diazepam-induced alterations in C57BL/6N and BALB/c mice using the modified hole board test.

F Ohl1, I Sillaber, E Binder, M E Keck, F Holsboer.   

Abstract

A variety of test procedures are used in preclinical research on behavioral pharmacology and to dissociate behavioral differences or pharmacologically induced behavioral alterations several independent tests are usually performed. In the present study we introduce a modified hole board procedure for mice which allows us to investigate a variety of behavioral parameters such as anxiety, risk assessment, exploration, locomotion, food-intake inhibition, novelty seeking, and arousal by using only one test. The modified hole board was established by investigating the behavior of two inbred mouse strains, C57BL/6 and BALB. Significant differences in terms of locomotor activity, general exploration, and other parameters were found. Moreover, strain-specific exploration strategies could be detected in the modified hole board. Further, the test was validated by investigating the effects of diazepam as standard anxiolytic on the behavior in both mouse strains. Acute administration of diazepam (1 and 3 mg/kg) induced strong sedative effects in a dose-dependent manner in C57BL/6 mice. In BALB mice, the lower dosage of diazepam showed an activating and anxiolytic action while the 3 mg dosage revealed a slight sedative but still anxiolytic effect in these animals. Taken together, the results demonstrate that the modified hole board enables to differentially investigate behavioral phenotypes and also pharmacologically-induced behavioral alterations in mice. Therefore, this new strategy allows to reduce the number of experimental animals and the time needed, thus, representing an effective screening-tool for behavioral investigations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461710     DOI: 10.1016/s0022-3956(01)00017-6

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  24 in total

Review 1.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

2.  Generation and characterization of dickkopf3 mutant mice.

Authors:  Ivan del Barco Barrantes; Ana Montero-Pedrazuela; Ana Guadaño-Ferraz; Maria-Jesus Obregon; Raquel Martinez de Mena; Valérie Gailus-Durner; Helmut Fuchs; Tobias J Franz; Svetoslav Kalaydjiev; Martina Klempt; Sabine Hölter; Birgit Rathkolb; Claudia Reinhard; Gabriella Morreale de Escobar; Juan Bernal; Dirk H Busch; Wolfgang Wurst; Eckhard Wolf; Holger Schulz; Svetlana Shtrom; Erich Greiner; Martin Hrabé de Angelis; Heiner Westphal; Christof Niehrs
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

3.  Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus.

Authors:  Aniela Wozniak; Natalia Scioscia; Patricia C García; James B Dale; Braulio A Paillavil; Paulette Legarraga; Francisco J Salazar-Echegarai; Susan M Bueno; Alexis M Kalergis
Journal:  Microbiol Immunol       Date:  2018-06-11       Impact factor: 1.955

4.  Mapping the living mouse brain neural architecture: strain-specific patterns of brain structural and functional connectivity.

Authors:  Meltem Karatas; Vincent Noblet; Md Taufiq Nasseef; Thomas Bienert; Marco Reisert; Jürgen Hennig; Ipek Yalcin; Brigitte Lina Kieffer; Dominik von Elverfeldt; Laura-Adela Harsan
Journal:  Brain Struct Funct       Date:  2021-02-26       Impact factor: 3.270

Review 5.  The age of anxiety: role of animal models of anxiolytic action in drug discovery.

Authors:  John F Cryan; Fabian F Sweeney
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred mouse strains.

Authors:  Dayna M Hayes; Darin J Knapp; George R Breese; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2005-05       Impact factor: 3.455

7.  The response of C57BL/6J and BALB/cJ mice to increased housing density.

Authors:  Anthony Nicholson; Rachel D Malcolm; Phillip L Russ; Kristin Cough; Chadi Touma; Rupert Palme; Michael V Wiles
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-11       Impact factor: 1.232

8.  Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine.

Authors:  Inge Sillaber; Markus Panhuysen; Markus S H Henniger; Frauke Ohl; Claudia Kühne; Benno Pütz; Thomas Pohl; Jan M Deussing; Marcelo Paez-Pereda; Florian Holsboer
Journal:  Psychopharmacology (Berl)       Date:  2008-07-16       Impact factor: 4.530

9.  A novel method for automatic quantification of psychostimulant-evoked route-tracing stereotypy: application to Mus musculus.

Authors:  Stephen J Bonasera; A Katrin Schenk; Evan J Luxenberg; Laurence H Tecott
Journal:  Psychopharmacology (Berl)       Date:  2007-12-21       Impact factor: 4.530

10.  Microphthalmia, parkinsonism, and enhanced nociception in Pitx3 ( 416insG ) mice.

Authors:  Michael Rosemann; Alesia Ivashkevich; Jack Favor; Claudia Dalke; Sabine M Hölter; Lore Becker; Ildikó Rácz; Ines Bolle; Martina Klempt; Birgit Rathkolb; Svetoslav Kalaydjiev; Thure Adler; Antonio Aguilar; Wolfgang Hans; Marion Horsch; Jan Rozman; Julia Calzada-Wack; Sandra Kunder; Beatrix Naton; Valerie Gailus-Durner; Helmut Fuchs; Holger Schulz; Johannes Beckers; Dirk H Busch; J Peter H Burbach; Marten P Smidt; Leticia Quintanilla-Martinez; Irene Esposito; Thomas Klopstock; Martin Klingenspor; Markus Ollert; Eckhard Wolf; Wolfgang Wurst; Andreas Zimmer; Martin Hrabé de Angelis; Michael Atkinson; Ulrich Heinzmann; Jochen Graw
Journal:  Mamm Genome       Date:  2009-12-22       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.